SPONSOR
Uppsala University
Total Trials
10
Recruiting
10
Phases
Phase 1, Phase 2
Conditions studied: Malignant MelanomaB-cell LymphomaShameSepsisThumb OsteoarthritisThumb Carpometacarpal Joint OsteoarthritisCarpometacarpal (CMC) Joint ArthritisBasal Thumb OsteoartrithisChronic Obstructive Pulmonary DiseaseBrain Tumor
Uppsala University is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Malignant Melanoma, B-cell Lymphoma, Shame, Sepsis.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Uppsala University
How many clinical trials has Uppsala University sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Uppsala University, of which 10 are actively recruiting participants. These trials cover conditions including Malignant Melanoma, B-cell Lymphoma, Shame. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Uppsala University research focus on?
Uppsala University clinical trials span Malignant Melanoma, B-cell Lymphoma, Shame, Sepsis, Thumb Osteoarthritis, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Uppsala University clinical trial?
To participate in a Uppsala University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Uppsala University trials with current recruitment status updated daily.
Clinical Trials by Uppsala University
NCT03116412
Recruiting
A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
Malignant Melanoma
NCT06002659 Phase 1, Phase 2
Recruiting
CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
B-cell Lymphoma
NCT07206966
Recruiting
Validation of the Swedish Translation of a Brief Shame Measure, the External and Internal Shame Scale
Shame
NCT06512129
Recruiting
Defining Volume Status in Sepsis With Extracellular Water Measurement
Sepsis
NCT07569549
Recruiting
Surgery for Thumb Base Osteoarthritis: Joint Replacement vs. Trapeziectomy
Thumb Osteoarthritis
NCT06335992
Recruiting
Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.
Chronic Obstructive Pulmonary Disease
NCT07381959
Recruiting
Biomarkers of Brain Injury in Children With Brain Tumors
Brain Tumor
NCT07273409
Recruiting
Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not
Pancreatic Neuroendocrine Tumor
NCT05763966
Recruiting
Uppsala Psychosis Cohort
Schizophrenia; Psychosis
NCT06084520
Recruiting
Translation and Validation of the COMM and ASI-SR
Opioid Use
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology